# Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee

> **NCT03101163** · PHASE2 · COMPLETED · sponsor: **KLSMC Stem Cells, Inc.** · enrollment: 120 (estimated)

## Conditions studied

- Articular Cartilage Disorder of Knee
- Articular Cartilage; Degeneration

## Interventions

- **BIOLOGICAL:** Autologous peripheral blood stem cells and hyaluronic acid
- **OTHER:** Hyaluronic acid

## Key facts

- **NCT ID:** NCT03101163
- **Lead sponsor:** KLSMC Stem Cells, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101163, "Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03101163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*